Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06728969 · ClinicalTrials.gov registry record · NA

A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.

A NA study of ADHD, sponsored by MindTension.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT06728969 is a NA study of ADHD that is actively recruiting participants, run by MindTension. The registered enrollment target is 120 participants, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06728969, a NA study of ADHD, is actively recruiting participants, sponsored by MindTension.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study aims to demonstrate the accuracy of the MT1 algorithm using the MindTension biometric sensor device as a diagnostic aid for healthcare providers in diagnosing ADHD in youth ages ≥ 6 to ≤17 years.

Conditions Studied

Interventions

  • DEVICE MT1 Auditory startle response patterns analysis algorithm
  • DEVICE T.O.V.A. Continuous Performance Test

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2024-06-02
Est. Completion 2026-06
Phase NA

Sponsor

MindTension

1 total trials

What the Registry Record Tells You About NCT06728969

The ClinicalTrials.gov registry entry for NCT06728969 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 189-participant average among 75 other ADHD trials with a reported enrollment target (37% lower). The listed sponsor is MindTension, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which MT1 Auditory startle response patterns analysis algorithm is the first listed.

NCT06728969 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06728969 about?

NCT06728969 is a clinical study titled "A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.". This study aims to demonstrate the accuracy of the MT1 algorithm using the MindTension biometric sensor device as a diagnostic aid for healthcare providers in diagnosing ADHD in youth ages ≥ 6 to ≤17 years.

What is the current status of trial NCT06728969?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-06-02. Estimated completion is 2026-06.

What conditions does trial NCT06728969 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT06728969?

The interventions under investigation include: MT1 Auditory startle response patterns analysis algorithm (DEVICE), T.O.V.A. Continuous Performance Test (DEVICE).

Who is sponsoring clinical trial NCT06728969?

This trial is sponsored by MindTension, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06728969 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.